semaglutide adverse events Efficacy and safety of 2.4 mg by race and ethnicity: A post hoc analysis of three randomized controlled trials - Rubino - 2024 - Obesity The obesity drug semaglutide (Wegovy)

J Pain 2017;18:42-53.ArticlePubMed 76

A patient may have excess weight, high blood pressure, insulin resistance, high triglycerides, low HDL cholesterol, inflammation, fatty liver risk, poor sleep, and low muscle mass at the same time

Product Info Molecular formula: C19H28N6O6 Molecular weight: 390.46 Purity: 99%+ Sequence: Ala-Glu-Asp-Gly Most standard lyophilized research vials are commonly prepared using 2mL of bacteriostatic water unless otherwise specified directly on the product page or vial label

Best For: Clients beginning their weight loss journey

*Compounded tirzepatide is not covered by insurance, and the out-of-pocket cost for the medication depends on the dose of the medication

Bite reactions also typically last longer than individual hives